Delivery Order SPE2DB20D2014-SPE2DB25FB94H

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,448.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,939,754 units of Trelegy Ellipta 200-62.5-25 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $8,669.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Trelegy Ellipta 100-62.5-25 60S, with a period of performance through June 24, 2024. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,460.38 delivery order contract is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $12,141.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the medication Trelegy Ellipta 100-62.5-25 60S, with a completion date of April 24, 2025. The contract is a firm fixed-price, non-set-aside agreement. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order worth $35,591.88 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication, with a period of performance through May 9, 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $9,710.45 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The award has a firm fixed price and an ultimate completion date of May 12, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $10,998.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4,568,078,175 units of the medication TRELEGY ELLIPTA 100-62.5-25 60S. The contract is a firm fixed-price, non-set-aside award with a period of performance through April 30, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,137.59 firm fixed-price delivery order is for the supply of Trelegy Ellipta 200-62.5-25 60S, a specialized pharmaceutical product. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $17,897.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price arrangement and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,376.20 firm fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of August 9, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB94H
    Delivery Order

This federal contract award, valued at $5,556.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 14, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract, indicating open competition.

Generated 8/12/25, 11:59 AM